- Home
- BRTX vs CARV Comparison
BRTX vs CARV Comparison
Compare BRTX & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- CARV
- Stock Information
- Founded
- BRTX 1997
- CARV 1948
- Country
- BRTX United States
- CARV United States
- Employees
- BRTX N/A
- CARV N/A
- Industry
- BRTX Managed Health Care
- CARV Savings Institutions
- Sector
- BRTX Health Care
- CARV Finance
- Exchange
- BRTX Nasdaq
- CARV Nasdaq
- Market Cap
- BRTX 12.5M
- CARV 13.0M
- IPO Year
- BRTX N/A
- CARV 1994
- Fundamental
- Price
- BRTX $1.62
- CARV $2.50
- Analyst Decision
- BRTX Strong Buy
- CARV
- Analyst Count
- BRTX 1
- CARV 0
- Target Price
- BRTX $18.00
- CARV N/A
- AVG Volume (30 Days)
- BRTX 89.7K
- CARV 68.6K
- Earning Date
- BRTX 08-12-2025
- CARV 08-13-2025
- Dividend Yield
- BRTX N/A
- CARV N/A
- EPS Growth
- BRTX N/A
- CARV N/A
- EPS
- BRTX N/A
- CARV N/A
- Revenue
- BRTX $391,000.00
- CARV $21,046,000.00
- Revenue This Year
- BRTX $216.71
- CARV N/A
- Revenue Next Year
- BRTX $60.63
- CARV N/A
- P/E Ratio
- BRTX N/A
- CARV N/A
- Revenue Growth
- BRTX 161.54
- CARV N/A
- 52 Week Low
- BRTX $1.21
- CARV $1.30
- 52 Week High
- BRTX $2.55
- CARV $3.20
- Technical
- Relative Strength Index (RSI)
- BRTX 48.45
- CARV 68.76
- Support Level
- BRTX $1.43
- CARV $1.79
- Resistance Level
- BRTX $1.75
- CARV $3.20
- Average True Range (ATR)
- BRTX 0.12
- CARV 0.31
- MACD
- BRTX 0.01
- CARV 0.06
- Stochastic Oscillator
- BRTX 52.78
- CARV 52.70
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.